Skip to main content
Shanghai Sanyou Medical Co., Ltd. logo

Shanghai Sanyou Medical Co., Ltd. — Investor Relations & Filings

Ticker · 688085 ISIN · CNE1000040J7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2026-06-04 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688085

About Shanghai Sanyou Medical Co., Ltd.

https://www.sanyoumed.com/

Shanghai Sanyou Medical Co., Ltd. focuses on the research, development, manufacturing, and distribution of orthopedic implants and instruments. The company provides a comprehensive range of products for spinal and trauma treatments, including pedicle screw systems, interbody fusion cages, and trauma fixation plates. Its research and development process is characterized by close collaboration with clinical experts to ensure products meet specific surgical needs and improve patient outcomes. The company utilizes advanced manufacturing technologies to produce high-precision medical components, supporting both traditional and minimally invasive surgical techniques. Its portfolio addresses various clinical conditions, from degenerative disc diseases to complex bone fractures, through a commitment to technical innovation and quality assurance in the production of surgical hardware.

Recent filings

Filing Released Lang Actions
关于注销部分募集资金专项账户的公告
Capital/Financing Update Classification · 80% confidence The document is a Chinese stock exchange announcement detailing the closure (注销) of special bank accounts established for managing proceeds from the company’s IPO and subsequent follow-on financing. It reviews the amounts raised, validation reports, and the regulatory agreements, then states the board resolution to close these fundraising accounts and reallocate surplus to working capital. This falls under updates on the management and usage of proceeds from capital-raising activities, fitting the Capital/Financing Update category (CAP).
2026-06-04 Chinese
2025年年度股东会会议资料
AGM Information Classification · 100% confidence The document is titled as "2025年年度股东会会议资料" which translates to "2025 Annual General Meeting (AGM) Meeting Materials" for Shanghai Sanyou Medical Devices Co., Ltd. It contains detailed agenda items for the 2025 Annual General Meeting, including the 2025 Annual Report and its summary, the 2025 Board of Directors work report, profit distribution proposals, director remuneration proposals, capital changes, amendments to the company charter, and remuneration management system proposals. The document includes meeting instructions, agenda, and detailed proposals to be voted on at the AGM. It is clearly a set of materials prepared for the Annual General Meeting, not the Annual Report itself or other filings. The document length is about 15,000 characters, consistent with detailed AGM materials. Therefore, the document fits the category of AGM Information (AGM-R).
2026-05-08 Chinese
东方证券股份有限公司关于上海三友医疗器械股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金及注销相关募集资金专户的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the completion of certain fundraising projects by Shanghai Sanyou Medical Devices Co., Ltd. It discusses the use and surplus of raised funds from initial public offerings and subsequent share issuances, including the permanent supplementation of surplus funds into working capital and the cancellation of related fundraising accounts. The document references regulatory rules on fundraising supervision and includes detailed financial figures and procedural approvals. It is not a full annual or interim financial report, nor an earnings release or call transcript. It is not a proxy, voting result, or management change announcement. The document is a formal verification and opinion report related to capital raising and fund usage, which fits the category of Capital/Financing Update (CAP). The length and content indicate it is a substantive report, not merely an announcement of a report publication or a certification letter. Therefore, the appropriate classification is CAP with high confidence.
2026-04-27 Chinese
公司董事会关于2025年度独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of independent directors for the year 2025. It references regulatory requirements from the China Securities Regulatory Commission and the Shanghai Stock Exchange, focusing on governance and compliance with independence rules for directors. The content is about board/management information related to director independence and qualifications, not a financial report or announcement of voting results. The document length is short and it is a standalone report on board/management matters, fitting the Board/Management Information category.
2026-04-27 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled "上海三友医疗器械股份有限公司2025 年年度报告摘要" which translates to "Shanghai Sanyou Medical Device Co., Ltd. 2025 Annual Report Summary." It contains detailed descriptions of the company's business, products, research and development, procurement, production, and sales operations. The document includes financial and operational information typical of an annual report summary. The length is 15,000 characters, indicating a substantive report rather than a brief announcement. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document is best classified as an Annual Report (10-K). FY 2025
2026-04-27 Chinese
关于参加2025年度医疗器械行业集体业绩说明会暨2026年第一季度业绩暨现金分红说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an investor performance explanation meeting for the 2025 annual results and 2026 Q1 results, including cash dividend information. It provides details about the meeting time, location, format, and how investors can participate and ask questions. It references the prior publication of the 2025 Annual Report and 2026 Q1 Report but does not contain actual financial data or detailed financial statements itself. The document is short (1585 characters) and serves as a notice for an upcoming investor presentation event rather than the report or transcript itself. Therefore, it fits best as an Investor Presentation (IP) announcement or related meeting notice. However, since it is primarily an announcement of the meeting and not the presentation materials themselves, and given the detailed description of the meeting and interaction, the best classification is Investor Presentation (IP).
2026-04-27 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.